C142H168N42O4 — CID 157126711
1-[2-[5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;1-[2-[5-[5-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;methane;1-[[5-[3-(7-piperazin-1-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]methyl]piperidin-4-ol;7-piperazin-1-yl-2-[5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridine;1-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol (PubChem CID 157126711) has the molecular formula C142H168N42O4 and a molecular weight of 2527.20 g/mol. Its IUPAC name is 1-[2-[5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;1-[2-[5-[5-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;methane;1-[[5-[3-(7-piperazin-1-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]methyl]piperidin-4-ol;7-piperazin-1-yl-2-[5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridine;1-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol.
| Compound Name | 1-[2-[5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;1-[2-[5-[5-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;methane;1-[[5-[3-(7-piperazin-1-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]methyl]piperidin-4-ol;7-piperazin-1-yl-2-[5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridine;1-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol |
|---|---|
| PubChem CID | 157126711 |
| Molecular Formula | C142H168N42O4 |
| Molecular Weight | 2527.20 g/mol |
| Exact Mass | 2525.42 |
| IUPAC Name | 1-[2-[5-[5-(azetidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;1-[2-[5-[5-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol;methane;1-[[5-[3-(7-piperazin-1-yl-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]methyl]piperidin-4-ol;7-piperazin-1-yl-2-[5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridine;1-[2-[5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazol-3-yl]-3H-imidazo[4,5-c]pyridin-7-yl]piperidin-4-ol |
| SMILES | C.C.C.C.C.CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCC(O)CC6)cncc5[nH]4)c3c2)c1.OC1CCN(Cc2cncc(-c3ccc4[nH]nc(-c5nc6c(N7CCNCC7)cncc6[nH]5)c4c3)c2)CC1.OC1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCC7)c6)cc45)nc23)CC1.OC1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)cc45)nc23)CC1.c1ncc(-c2ccc3[nH]nc(-c4nc5c(N6CCNCC6)cncc5[nH]4)c3c2)cc1CN1CCCCC1 |
| InChI | InChI=1S/C28H31N9O.C28H31N9.C28H30N8O.C27H28N8O.C26H28N8O.5CH4/c38-21-3-7-36(8-4-21)17-18-11-20(14-30-13-18)19-1-2-23-22(12-19)26(35-34-23)28-32-24-15-31-16-25(27(24)33-28)37-9-5-29-6-10-37;1-2-8-36(9-3-1)18-19-12-21(15-30-14-19)20-4-5-23-22(13-20)26(35-34-23)28-32-24-16-31-17-25(27(24)33-28)37-10-6-29-7-11-37;37-21-5-9-36(10-6-21)25-16-30-15-24-27(25)32-28(31-24)26-22-12-19(3-4-23(22)33-34-26)20-11-18(13-29-14-20)17-35-7-1-2-8-35;36-20-4-8-35(9-5-20)24-15-29-14-23-26(24)31-27(30-23)25-21-11-18(2-3-22(21)32-33-25)19-10-17(12-28-13-19)16-34-6-1-7-34;1-33(2)15-16-9-18(12-27-11-16)17-3-4-21-20(10-17)24(32-31-21)26-29-22-13-28-14-23(25(22)30-26)34-7-5-19(35)6-8-34;;;;;/h1-2,11-16,21,29,38H,3-10,17H2,(H,32,33)(H,34,35);4-5,12-17,29H,1-3,6-11,18H2,(H,32,33)(H,34,35);3-4,11-16,21,37H,1-2,5-10,17H2,(H,31,32)(H,33,34);2-3,10-15,20,36H,1,4-9,16H2,(H,30,31)(H,32,33);3-4,9-14,19,35H,5-8,15H2,1-2H3,(H,29,30)(H,31,32);5*1H4 |
| InChIKey | AIOXQCKWWKENEH-UHFFFAOYSA-N |
| XLogP | 21.50 |
| TPSA | 553.08 Ų |
| H-Bond Donors | 16 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 25 |
| Heavy Atoms | 188 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2527.20 |
| LogP ≤ 5 | 21.50 |
| H-Bond Donors ≤ 5 | 16 |
| H-Bond Acceptors ≤ 10 | 36 |